Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.

Despite the proven efficacy of warfarin, its use in patients with Atrial Fibrillation (AF) is reportedly low. We investigated the underuse and overuse of warfarin in the management of AF in general practices in the United Kingdom (UK) against the National Institute of Clinical Excellence (NICE, UK)...

Full description

Bibliographic Details
Main Authors:	Mohammed A Mohammed, Tom Marshall, Krishnarajah Nirantharakumar, Andrew Stevens, David Fitzmaurice
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3642100?pdf=render

Similar Items

The use of warfarin in veterans with atrial fibrillation
by: Rosenbeck Karen, et al.
Published: (2004-10-01)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
by: Mavaddat, N, et al.
Published: (2014)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
by: Jowett, S, et al.
Published: (2011)

Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom
by: González-Pérez A, et al.
Published: (2022-11-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Rates of hemorrhage during warfarin therapy for atrial fibrillation
by: S.A. Punekar, et al.
Published: (2014-11-01)

Research into practice: management of atrial fibrillation in general practice.
by: Fitzmaurice, D, et al.
Published: (2014)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
by: Mant, J, et al.
Published: (2007)

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
by: Mavaddat, N, et al.
Published: (2014)

Association of obesity with incident atrial fibrillation in Korea and the United Kingdom
by: Sung Hwa Choi, et al.
Published: (2023-03-01)

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis
by: Baczek Victoria L, et al.
Published: (2012-02-01)

The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
by: Bungard, T, et al.
Published: (2003)

Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture)
by: Y. V. Shubik
Published: (2015-12-01)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
by: A. B. Sumarokov
Published: (2013-08-01)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
by: Carolina eMalta Hansen, et al.
Published: (2012-06-01)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
by: Touchette DR,, et al.
Published: (2008-03-01)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
by: Sana Rashid, et al.
Published: (2021-12-01)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020-06-01)

Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
by: Yukihiko Yoshida, et al.
Published: (2018-04-01)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
by: Hobbs, R, et al.
Published: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
by: Hobbs, F, et al.
Published: (2011)

Increased Cardiometabolic and Mortality Risk Following Childhood Maltreatment in the United Kingdom
by: Joht Singh Chandan, et al.
Published: (2020-05-01)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
by: Mant, J, et al.
Published: (2008)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
by: Bungard, T, et al.
Published: (2001)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
by: Jeremy Petch, et al.
Published: (2024-02-01)

INCREASED ADHERENCE TO WARFARIN TREATMENT WITH TRAINING PROGRAMS IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Djishambaev, et al.
Published: (2020-12-01)

Warfarin therapy in atrial fibrillation: assessment of patient knowledge of risks and benefits
by: P. Fitzgerald, et al.
Published: (2020-05-01)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
by: Choi JC, et al.
Published: (2014-02-01)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
by: Antonio de Padua Mansur, et al.
Published: (2012-01-01)

Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
by: Chung-Ming Fu, et al.
Published: (2021-10-01)

Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation.
by: Soyon Lee, et al.
Published: (2012-01-01)

Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
by: Cesare Greco
Published: (2015-08-01)

Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
by: Cavalcante Joao, et al.
Published: (2008-06-01)

A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation
by: Miney Paquette, et al.
Published: (2019-10-01)

Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors
by: Vineet Kumar, et al.
Published: (2024-02-01)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
by: Line Melgaard, et al.
Published: (2021-12-01)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)